13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001104659-25-078521
Total Value
$771.9M
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | APGE | 2,048,647 | $89.0M | 11.53% |
| 2 | AXSOME THERAPEUTICS INC | AXSM | 815,176 | $85.1M | 11.02% |
| 3 | ENLIVEN THERAPEUTICS INC | ELVN | 3,711,444 | $74.5M | 9.65% |
| 4 | SCHOLAR ROCK HLDG CORP | SRRK | 1,824,031 | $64.6M | 8.37% |
| 5 | SPYRE THERAPEUTICS INC | SYRE | 4,018,101 | $60.2M | 7.79% |
| 6 | NUVALENT INC | NUVL | 727,563 | $55.5M | 7.19% |
| 7 | DIANTHUS THERAPEUTICS INC | DNTH | 2,707,191 | $50.4M | 6.53% |
| 8 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 1,772,839 | $49.1M | 6.36% |
| 9 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,459,913 | $48.4M | 6.27% |
| 10 | COGENT BIOSCIENCES INC | COGT | 6,225,641 | $44.7M | 5.79% |
| 11 | ORUKA THERAPEUTICS INC | ORKA | 3,371,922 | $37.8M | 4.90% |
| 12 | JADE BIOSCIENCES INC | JBIO | 3,220,368 | $32.2M | 4.17% |
| 13 | CRESCENT BIOPHARMA INC. | CBIO | 1,387,866 | $22.4M | 2.90% |
| 14 | ASTRIA THERAPEUTICS INC | 04635X102 | 3,554,129 | $19.1M | 2.47% |
| 15 | ZENAS BIOPHARMA INC | ZBIO | 1,892,806 | $18.3M | 2.38% |
| 16 | INHIBIKASE THERAPEUTICS INC | IKT | 6,125,000 | $11.9M | 1.55% |
| 17 | CYTOMX THERAPEUTICS INC | CTMX | 3,896,582 | $8.8M | 1.15% |